Celcuity Inc.

OVERVALUEDCELC · NASDAQ · Healthcare
CELC·NASDAQ·Healthcare
OVERVALUED
Celcuity Inc.
55.6%downside
MARKET PRICE
$119.61
FAIR PRICE
$53.10
MARGIN
$66.50
UNDERVALUEDFAIROVERVALUED
P/E RATIO
N/A
DIV. YIELD
N/A
ROE
-203.2%
MARKET CAP
$6B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

55.6%downside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$119.61

FAIR PRICE

$53.10

MARGIN

$66.50

UNDERVALUEDFAIROVERVALUED

P/E Ratio

N/A

Div. Yield

N/A

ROE

-203.2%

Average

Market Cap

$6B

Mid-cap

NOW AVAILABLE

Get notified when CELC's fair price changes

Push notifications when CELC's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

2.3/ 10

Low debt levels and stable earnings and revenue, but below-average fundamental quality and expensive valuation relative to fundamentals.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$42.48CONSERVATIVE ENTRY
$53.10FAIR PRICE
$119.61MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$42.48

Fair price × 0.80

DISTANCE

64.5%

Price to entry level

At the current price of $119.61, CELC trades 64.5% above the conservative entry level of $42.48. This entry level represents a 20% margin of safety below the calculated fair price of $53.10 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate CELC's fair price

Celcuity Inc.'s fair price of $53.10 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $119.61, CELC trades 55.6% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting CELC's risk profile.

RELATIVE · 30%

Comparing CELC's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for CELC, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate CELC's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for CELC.

Explore on Bulios

FAQ

What is the fair price of CELC?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Celcuity Inc. is $53.10. At the current market price of $119.61, CELC trades 55.6% above its calculated fair value.

Is CELC overvalued or undervalued?+

Celcuity Inc. is currently overvalued based on our valuation model. The stock trades at $119.61, which is 55.6% above the fair price of $53.10.

What is the margin of safety for CELC?+

With a 20% margin of safety applied to the fair price of $53.10, the conservative entry level for CELC is $42.48. At the current market price of $119.61, the stock trades 64.5% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is CELC's fair price updated?+

We update fair price calculations for CELC daily after market close. The current fair price of $53.10 incorporates the latest market data and sector multiples.

What factors affect CELC's fair price calculation?+

CELC's fair price of $53.10 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -203.2%.

Is CELC a good buy right now?+

At $119.61, CELC trades 55.6% above our fair value estimate of $53.10. The stock is currently overvalued. ROE stands at -203.2% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does CELC pay dividends?+

CELC does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.